Status:

COMPLETED

Granzymes and Perforin at the Onset of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

Lead Sponsor:

University of Thessaly

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

18-90 years

Brief Summary

COPD exacerbations are characterized by an excessive accumulation and activation of inflammatory cells in the airways. It is not known whether this phenomenon represents a risk for for lung damage via...

Detailed Description

The course of Chronic Obstructive Pulmonary Disease (COPD) is characterized by exacerbations which lead to significant clinical deterioration and morbidity.COPD exacerbations are characterized by an a...

Eligibility Criteria

Inclusion

  • COPD patients
  • All COPD patients who seek medical assistance at the clinic during the study period will be asked about COPD exacerbation related symptoms-medical history and then they will be included in the study if they satisfied all the following criteria:
  • COPD diagnosis according to the GOLD Consensus Statement
  • initiation of symptoms diagnostic for COPD exacerbation in the past 72 hours
  • abstention from any new therapeutic intervention
  • absence of any signs suggestive of severe exacerbation requiring hospitalization
  • Control subjects
  • Subjects who seek medical assistance at respiratory clinic for symptoms suggesting acute bronchitis (dyspnea, sputum production, purulence, wheeze, cough)
  • medical history free of COPD, Asthma, pneumonia, other chronic respiratory disease or congestive cardiac failure,
  • initiation of symptoms in the past 72 hours,
  • abstention from any new therapeutic intervention, and
  • absence of any signs suggestive of clinical condition requiring hospitalization.

Exclusion

  • Patients with Asthma or other respiratory disease will be excluded from this study

Key Trial Info

Start Date :

December 1 2002

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2009

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00883701

Start Date

December 1 2002

End Date

September 1 2009

Last Update

April 29 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Larisa

Larissa, Thessaly, Greece